Literature DB >> 8339458

Parathyroid carcinoma: 50-year experience at The Cleveland Clinic Foundation.

A G Hakaim1, C B Esselstyn.   

Abstract

BACKGROUND: Parathyroid carcinoma is rare, with a reported prevalence of 0.6% to 4.0% in patients presumed to have primary hyperparathyroidism. This study examines the long-term results of surgical therapy and combination chemotherapy. PATIENTS: From 1938 to 1988, 1260 operations for primary hyperparathyroidism were performed; only six patients (0.47%) were subsequently found to have parathyroid carcinoma. A seventh patient was referred to our institution after the diagnosis of parathyroid carcinoma had been made.
RESULTS: All patients had excessive hypercalcemia (serum calcium concentration > 12.0 mg/dL) with a range of 12.3 to 18.3 mg/dL. Locally recurrent tumors causing recurrent hypercalcemia were managed by repeated neck exploration and tumor resection. Six of the seven patients (85%) survived 5 years, while four patients (57%) survived 10 years.
CONCLUSIONS: Diagnosis of parathyroid carcinoma rests upon postoperative surveillance of patients who have undergone previous neck exploration and resection of apparently benign adenomas. Long-term survival is possible with repeated resection of locally recurrent tumors.

Entities:  

Mesh:

Year:  1993        PMID: 8339458     DOI: 10.3949/ccjm.60.4.331

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  14 in total

Review 1.  Parathyroid cancer.

Authors:  Fiona McClenaghan; Yassar A Qureshi
Journal:  Gland Surg       Date:  2015-08

2.  Differential findings of tc-99m sestamibi dual-phase parathyroid scintigraphy between benign and malignant parathyroid lesions in patients with primary hyperparathyroidism.

Authors:  Miju Cheon; Joon Young Choi; Jae-Hoon Chung; Ji Young Lee; Sook Kyung Cho; Jang Yoo; Soo Bin Park; Kyung-Han Lee; Byung-Tae Kim
Journal:  Nucl Med Mol Imaging       Date:  2011-08-19

3.  Parathyroid carcinoma encountered after minimally invasive focused parathyroidectomy may not require further radical surgery.

Authors:  Christine J O'Neill; Conan Chan; James Symons; Diana L Learoyd; Stan B Sidhu; Leigh W Delbridge; Anthony Gill; Mark S Sywak
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

Review 4.  Parathyroid carcinoma.

Authors:  B Givi; J P Shah
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-05-26       Impact factor: 4.126

Review 5.  Parathyroid Carcinoma: a Review.

Authors:  Shikhar Sawhney; Richa Vaish; Siddhanth Jain; Neha Mittal; Suman Kumar Ankathi; Shivakumar Thiagarajan; Devendra Chaukar
Journal:  Indian J Surg Oncol       Date:  2021-06-03

6.  Mortality factors in recurrent parathyroid cancer: a pooled analysis.

Authors:  Wen-Hsuan Tsai; Yi-Hong Zeng; Chun-Chuan Lee; Ming-Chieh Tsai
Journal:  J Bone Miner Metab       Date:  2022-02-20       Impact factor: 2.626

Review 7.  Parathyroid carcinoma: etiology, diagnosis, and treatment.

Authors:  Takahiro Okamoto; Masatoshi Iihara; Takao Obara; Toshihiko Tsukada
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

8.  Hyperparathyroidism with hypercalcaemia in chronic kidney disease: primary or tertiary?

Authors:  Mitchell R Lunn; Jair Muñoz Mendoza; Lezlee J Pasche; Jeffrey A Norton; Alexander L Ayco; Glenn M Chertow
Journal:  NDT Plus       Date:  2010-05-05

9.  Parathyroid Carcinoma: A Single-Institution Experience with an Emphasis on Histopathological Features.

Authors:  Akash Pramod Sali; Priyal Motghare; Munita Bal; Neha Mittal; Swapnil Rane; Shubhada Kane; Asawari Patil
Journal:  Head Neck Pathol       Date:  2020-11-05

10.  Malignancy of parathyroid: An uncommon clinical entity.

Authors:  Kamran Ali; Rathindra Sarangi; Shashi Dhawan; Brij B Agarwal; Manish K Gupta
Journal:  Indian J Endocrinol Metab       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.